chrX-8170156-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_StrongBP6_Moderate
The NM_016378.3(VCX2):āc.296C>Gā(p.Thr99Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.0 ( 0 hom., 0 hem., cov: 8)
Exomes š: 0.000019 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control
Consequence
VCX2
NM_016378.3 missense
NM_016378.3 missense
Scores
1
16
Clinical Significance
Conservation
PhyloP100: -1.49
Genes affected
VCX2 (HGNC:18158): (variable charge X-linked 2) This gene belongs to the VCX/Y gene family, which has multiple members on both X and Y chromosomes that are expressed exclusively in male germ cells. The VCX gene cluster is polymorphic in terms of copy number; different individuals may have a different number of VCX genes. This gene contains two copies of a 30 nt tandem repeat. Deletion of a nearby member of this family was implicated in cognitive disability. [provided by RefSeq, Feb 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.03831759).
BP6
Variant X-8170156-G-C is Benign according to our data. Variant chrX-8170156-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 2221361.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VCX2 | NM_016378.3 | c.296C>G | p.Thr99Ser | missense_variant | 3/3 | ENST00000317103.5 | NP_057462.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VCX2 | ENST00000317103.5 | c.296C>G | p.Thr99Ser | missense_variant | 3/3 | 1 | NM_016378.3 | ENSP00000321309.4 | ||
ENSG00000285679 | ENST00000649338.1 | n.263-58179G>C | intron_variant | |||||||
ENSG00000285679 | ENST00000659022.1 | n.972-58179G>C | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 55435Hom.: 0 Cov.: 8 AF XY: 0.00 AC XY: 0AN XY: 6367 FAILED QC
GnomAD3 genomes
AF:
AC:
0
AN:
55435
Hom.:
Cov.:
8
AF XY:
AC XY:
0
AN XY:
6367
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000215 AC: 2AN: 93184Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 28516
GnomAD3 exomes
AF:
AC:
2
AN:
93184
Hom.:
AF XY:
AC XY:
0
AN XY:
28516
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000188 AC: 20AN: 1065386Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 343420
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
20
AN:
1065386
Hom.:
Cov.:
31
AF XY:
AC XY:
0
AN XY:
343420
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 55435Hom.: 0 Cov.: 8 AF XY: 0.00 AC XY: 0AN XY: 6367
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
55435
Hom.:
Cov.:
8
AF XY:
AC XY:
0
AN XY:
6367
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ESP6500AA
AF:
AC:
18
ESP6500EA
AF:
AC:
16
ExAC
AF:
AC:
3
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T
FATHMM_MKL
Benign
N
LIST_S2
Benign
T
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
N
MutationTaster
Benign
N
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
B
Vest4
MutPred
Loss of glycosylation at T99 (P = 0.0648);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at